申请人:Pfizer Inc.
公开号:US10851367B2
公开(公告)日:2020-12-01
The present application provides compounds, compositions, uses thereof for the treatment of diseases, conditions and/or disorders, and uses thereof as asialoglycoprotein receptor (ASGPR) targeting agents.
本申请提供了用于治疗疾病、病症和/或失调的化合物、组合物及其用途,以及其作为淀粉样糖蛋白受体(ASGPR)靶向药物的用途。